Statin Compounds Reduce Human Immunodeficiency Virus Type 1 Replication by Preventing the Interaction between Virion-Associated Host Intercellular Adhesion Molecule 1 and Its Natural Cell Surface Ligand LFA-1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Virology

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/JVI.78.21.12062-12065.2004PMID 15479847PMCID PMC523291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors.

  2003cited by this paper
• Presence of Host ICAM-1 in Laboratory and Clinical Strains of Human Immunodeficiency Virus Type 1 Increases Virus Infectivity and CD4+-T-Cell Depletion in Human Lymphoid Tissue, a Major Site of Replication In Vivo

  2002cited by this paper
• Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

  2001cited by this paper
• Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties.

  2001cited by this paper
• Lipid rafts and HIV-1: from viral entry to assembly of progeny virions.

  2001cited by this paper
• LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication.

  2000influential reference
• Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.

  1999cited by this paper
• Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection.

  1999cited by this paper
• T Cells Expressing Activated LFA-1 Are More Susceptible to Infection with Human Immunodeficiency Virus Type 1 Particles Bearing Host-Encoded ICAM-1

  1998cited by this paper
• Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity

  1997cited by this paper
• Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions

  1997cited by this paper
• The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific.

  1996cited by this paper
• Acquisition of host cell‐surface‐derived molecules by HIV‐1

  1996cited by this paper
• Pharmacology of competitive inhibitors of HMG-CoA reductase.

  1995cited by this paper
• A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles.

  1994cited by this paper
• The role of lymphoid organs in the pathogenesis of HIV infection.

  1993cited by this paper
• The immunopathogenesis of human immunodeficiency virus infection.

  1993cited by this paper
• The role of lymphoid organs in the immunopathogenesis of HIV infection

  1992cited by this paper

• Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens

  2025cites this paper
• Association between statin administration and Clostridium difficile-induced enteritis: a retrospective analysis of the MIMIC-IV database

  2025cites this paper
• The effects of statins on the function and differentiation of blood cells

  2022cites this paper
• Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection

  2022cites this paper
• Statins for primary cardiovascular disease prevention among people with HIV: emergent directions

  2022cites this paper
• Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an in silico investigation

  2022cites this paper
• Immunotherapy with Cell-Based Biological Drugs to Cure HIV-1 Infection

  2021cites this paper
• Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery

  2021cites this paper
• Regression QSAR Models for Predicting HIV-1 Integrase Inhibitors

  2021cites this paper
• Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets

  2021cites this paper
• Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

  2021cites this paper
• Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines

  2020cites this paper
• Overview of therapeutic effects of stains on inflammatory diseases through regulating adhesive molecules.

  2020cites this paper
• ICAM-1 in HIV infection and underlying mechanisms.

  2019cites this paper
• Statins & risk of Clostridium difficile infection: A meta-analysis

  2019cites this paper
• Inflammation During Virus Infection: Swings and Roundabouts

  2019cites this paper
• Recruitment via a CCL1 Dependent Pathway Statins Induce Regulatory T Cell

  2017cites this paper
• Evaluation of anti‐Zika virus activities of broad‐spectrum antivirals and NIH clinical collection compounds using a cell‐based, high‐throughput screen assay

  2017cites this paper
• Current use of statins reduces risk of HIV rebound on suppressive HAART

  2017cites this paper
• Current landscape and future prospects of antiviral drugs derived from microbial products

  2017cites this paper
• Étude de molécules antivirales originales ciblant les fonctions cellulaires et la réponse immunitaire innée

  2016cites this paper
• Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21

  2016cites this paper
• Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library

  2016cites this paper
• Anti-α4 Integrin Antibody Blocks Monocyte/Macrophage Traffic to the Heart and Decreases Cardiac Pathology in a SIV Infection Model of AIDS

  2015cites this paper
• The Role of Statins in the Setting of HIV Infection

  2015cites this paper
• Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells.

  2015cites this paper
• Antiviral drug discovery: broad-spectrum drugs from nature.

  2015cites this paper
• The future of antivirals: broad-spectrum inhibitors

  2015cites this paper
• Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial

  2015cites this paper
• The Evaluation of Statins as Potential Inhibitors of the LEDGF/p75–HIV‐1 Integrase interaction

  2015cites this paper
• Identification and evaluation of inhibitors targeting the HIV-1 integrase-LEDGF/p75 interaction

  2014cites this paper
• Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin

  2014cites this paper
• Are statins a viable option for the treatment of infections with the hepatitis C virus?

  2014cites this paper
• FRET Based Quantification and Screening Technology Platform for the Interactions of Leukocyte Function-Associated Antigen-1 (LFA-1) with InterCellular Adhesion Molecule-1 (ICAM-1)

  2014cites this paper
• Tenofovir/Emtricitabine/Efavirenz Plus Rosuvastatin Decrease Serum Levels of Inflammatory Markers More Than Antiretroviral Drugs Alone in Antiretroviral Therapy-Naive HIV-Infected Patients

  2014cites this paper
• Characterization of heme oxygenase 1 based therapy options in chronic persistent HCV infection

  2014cites this paper
• infected lymphocytes - polarization in HTLV-1 Engagement of specific T-cell surface molecules regulates cytoskeletal

  2013cites this paper
• Statins and Sepsis: Possible Connections and Therapeutic Implications

  2013cites this paper
• Annexin-A1 Regulates TLR-Mediated IFN-

  2013cites this paper
• Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?

  2013cites this paper
• Lipid Involvement in Viral Infections: Present and Future Perspectives for the Design of Antiviral Strategies

  2013influential citation
• Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk

  2013cites this paper
• Emerging Approaches in Fermentative Production of Statins

  2013cites this paper
• Annexin-A1 Regulates TLR-Mediated IFN-β Production through an Interaction with TANK-Binding Kinase 1

  2013cites this paper
• The n-butanol fraction of Naematoloma sublateritium suppresses the inflammatory response through downregulation of NF-κB in human endothelial cells.

  2012cites this paper
• Randomized clinical trial of lovastatin inHIV-infected, HAART na€ıve patients (NCT00721305)

  2012cites this paper
• Antiviral Drugs - Aspects of Clinical Use and Recent Advances

  2012cites this paper
• RandomizedclinicaltrialoflovastatininHIV-infected, HAART na€ive patients (NCT00721305)

  2012cites this paper
• The Effect of Rosuvastatin in a Murine Model of Influenza A Infection

  2012cites this paper
• CXCR4-Tropic, But Not CCR5-Tropic, Human Immunodeficiency Virus Infection Is Inhibited by the Lipid Raft-Associated Factors, Acyclic Retinoid Analogs, and Cholera Toxin B Subunit

  2012cites this paper
• Identification of old drugs as potential inhibitors of HIV-1 integrase – human LEDGF/p75 interaction via molecular docking

  2012cites this paper
• Statins as Antiviral and Anti-inflammatory Therapy in HIV Infection

  2012cites this paper
• VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics

  2012cites this paper
• Targeting Norovirus: Strategies for the Discovery of New Antiviral Drugs

  2012influential citation
• Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305).

  2012cites this paper
• Statins as anti-inflammatory therapy in HIV disease?

  2011cites this paper
• HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons

  2011cites this paper
• Synthesis of potent lymphocyte function‐associated antigen‐1 inhibitors labeled with carbon‐14 and deuterium, part 1

  2011cites this paper
• [Statins and asthma].

  2011cites this paper
• High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.

  2011cites this paper
• RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.

  2010cites this paper
• Posttranslational Modification of Proteins

  2010cites this paper
• New Insights into Structure and Replication of the Hepatitis C Virus and Clinical Implications

  2010cites this paper
• Cholesterol depletion affects infectivity and stability of pseudorabies virus.

  2010cites this paper
• Case Study: The Discovery of Potent LFA‐1 Antagonists

  2010cites this paper
• Statins potentiate the in vitro anti‐hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

  2009cites this paper
• Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial

  2009cites this paper
• Potential New Therapeutic Agents: Effects on HIV Replication and Viral Escape

  2009cites this paper
• diseasetherapeutic role for statins in respiratory

  2009cites this paper
• LFA-1 Antagonists as Agents Limiting Human Immunodeficiency Virus Type 1 Infection and Transmission and Potentiating the Effect of the Fusion Inhibitor T-20

  2009cites this paper
• Neurovirological Aspects of HIV Infection in the HAART Era

  2009cites this paper
• HIV entry in macrophages is dependent on intact lipid rafts

  2009cites this paper
• Host proteins incorporated by the Human Immunodeficiency Virus (HIV-1)

  2008cites this paper
• Human Immunodeficiency Virus (HIV-1)

  2008cites this paper
• Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication.

  2008cites this paper
• Effect of atorvastatin on asthma control and airway inflammation : a randomised controlled trial

  2008cites this paper
• Effectiveness of lipid-lowering therapy in HIV patients

  2008cites this paper
• Edición por APOBEC, un nuevo mecanismo de resistencia a la infección por el VIH-1

  2008cites this paper
• Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway1

  2008cites this paper
• Proteínas del huésped incorporadas en el Virus de la Inmunodeficiencia Humana tipo 1 (VIH-1)

  2008cites this paper
• Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease

  2007cites this paper
• Preoperative statins and infectious complications following cardiac surgery

  2007cites this paper
• HIV-associated dyslipidaemia: pathogenesis and treatment.

  2007cites this paper
• Statins and sepsis: multiple modifications at multiple levels.

  2007cites this paper
• Rosuvastatin Suppresses the Inflammatory Responses Through Inhibition of c-Jun N-terminal Kinase and Nuclear Factor-κB in Endothelial Cells

  2007cites this paper
• The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment

  2007cites this paper
• Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.

  2007cites this paper
• Statin use and sepsis events [corrected] in patients with chronic kidney disease.

  2007cites this paper
• Statins Disrupt CCR5 and RANTES Expression Levels in CD4+ T Lymphocytes In Vitro and Preferentially Decrease Infection of R5 Versus X4 HIV-1

  2007cites this paper
• Modulation of host metabolism as a target of new antivirals

  2007cites this paper
• Attachment of human immunodeficiency virus to cells and its inhibition

  2007cites this paper
• The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System

  2007cites this paper
• Preventing the binding of pathogens to the host by controlling sphingolipid metabolism.

  2006cites this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE.

  2006cites this paper
• Potential therapeutic role for statins in respiratory disease

  2006cites this paper
• Dendritic cell-mediated HIV-1 transmission to T cells of LAD-1 patients is impaired due to the defect in LFA-1

  2006cites this paper
• Statins reduce cholesterol levels by inhibiting 3-hydroxy-3-methylglutaryl coenzyme

  2006cites this paper
• Characterization and Role of Lentivirus-Associated Host Proteins

  2006cites this paper
• The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy

  2006cites this paper
• Studies of HTLV-1 p12(I) in calcineurin binding, calcium-mediated cell signalling and viral transmission

  2006cites this paper